PBMCs from SS patients have the capacity to secrete IL-17 and IL-12 which skew naïve CD4+ T cells to Th1 and Th17 cells respectively, thereby facilitating initiation of the auto-immune cascade [136]. This evidence concerns the gene IL17A and synovial sarcoma.